Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Dermatology Online Journal|March 11, 2020
Long-term follow-up of 22 psoriatic patients treated with ixekizumab after failure of secukinumabK Amschler, S Phillip, J Mohr, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcomeS Abbasi, D Hirsch, J Davis, et al.
Journal of Leukocyte Biology|January 1, 1984
Decreased fibronectin biosynthesis by human cord blood mononuclear phagocytes in vitroJ S Gerdes, S D Douglas, G B Kolski, et al.
Archives of Dermatological Research|April 7, 2016
The German National Program on Psoriasis Health Care 2005-2015: results and experiencesM Augustin, L Eissing, A Langenbruch, et al.
The British Journal of Dermatology|September 12, 2015
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)C Paul, J Cather, M Gooderham, et al.
Plos One|March 18, 2014
Early detection of widespread progressive brain injury after cardiac arrest: a single case DTI and post-mortem histology studyJan S Gerdes, Ernst U Walther, Suad Jaganjac, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2017
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasisA Blauvelt, K A Papp, H Sofen, et al.
The Journal of Pediatrics|April 1, 1986
Tracheal lavage and plasma fibronectin: relationship to respiratory distress syndrome and development of bronchopulmonary dysplasiaJ S Gerdes, M C Yoder, S D Douglas, et al.
Journal of the American Academy of Dermatology|April 29, 1998
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trialP Mayser, U Mrowietz, P Arenberger, et al.
American Journal of Obstetrics and Gynecology|October 28, 2004
The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infantsHarish M Sehdev, Soraya Abbasi, Patricia Robertson, et al.
Pageof 23